Anika Therapeutics Files 2024 10-K
Ticker: ANIK · Form: 10-K · Filed: Mar 17, 2025 · CIK: 898437
| Field | Detail |
|---|---|
| Company | Anika Therapeutics, Inc. (ANIK) |
| Form Type | 10-K |
| Filed Date | Mar 17, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, medical-devices
TL;DR
Anika Therapeutics filed its 2024 10-K. Full financials and biz details out now.
AI Summary
Anika Therapeutics, Inc. filed its 2024 10-K report on March 17, 2025, detailing its fiscal year ending December 31, 2024. The company, based in Bedford, MA, operates in the surgical and medical instruments sector. The filing covers financial performance and business operations for the fiscal year 2024.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Anika Therapeutics' financial health, operational performance, and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a medical device company, Anika Therapeutics is subject to regulatory, market, and competitive risks inherent in the healthcare industry.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period covered by the financial statements in the 10-K.)
- 2025-03-17 — Filing Date (The date Anika Therapeutics submitted its 10-K to the SEC.)
Key Players & Entities
- Anika Therapeutics, Inc. (company) — Filer of the 10-K
- 32 WIGGINS AVENUE, BEDFORD, MA 01730 (location) — Company's business and mailing address
- 001-14027 (other) — SEC file number
- 20241231 (date) — Fiscal year end date
- 20250317 (date) — Filing date of the 10-K
FAQ
What is Anika Therapeutics' primary business segment?
Anika Therapeutics operates within the 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS' industry, with SIC code 3841.
What is the company's main address?
The company's business and mailing address is 32 WIGGINS AVENUE, BEDFORD, MA 01730.
When did the company change its name from Anika Research Inc.?
The company's name changed from Anika Research Inc. on January 14, 1997.
What is the SEC file number for Anika Therapeutics?
The SEC file number for Anika Therapeutics is 001-14027.
What fiscal year does this 10-K report cover?
This 10-K report covers the fiscal year ending December 31, 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 17, 2025 regarding Anika Therapeutics, Inc. (ANIK).